Loading...

Edward Ball

Title(s)Professor, Medicine
SchoolHealth Sciences
Address9500 Gilman Drive #0960
La Jolla CA 92093
Phone858-822-6600
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Research Interests
    Dr. Ball’s research focuses on the development of monoclonal antibody (mAb)-targeted immunotherapy and its translation to the treatment of patients with malignancy. His lab produced mAbs to myeloid-associated antigens expressed on myeloid leukemia cells. These antibodies have been used clinically for the diagnosis and treatment of acute myeloid leukemia (AML).He has conducted multi-center clinical trials using antibody-mediated purging using the AML cells from the marrow of patients with leukemia prior to transplantation, after high dose chemotherapy. He has also developed in vivo therapeutics using an anti-CD15 mAb and a bispecific antibody. This bispecific antibody (251xH22) mediates antibody–directed cellular cytotoxicity(ADCC) of AML cells mediated by normal leukocyte cells including natural killer cells, monocytes and granulocytes. They determined that there are direct signals transduced by binding of the anti-CD33 monoclonal antibody that lead to death of AML cells mediated in part by the protein kinase Syk. This led to an investigator-initiated multi-center Phase I/II clinical trial combining 5-azacytidine (that increases Syk expression) and the anti-CD33 monoclonal antibody Mylotarg. His laboratory has also been working the generation of cytotoxic T cells in vitro in a novel culture system. Based on this pre-clinical work, they developed a clinical trial wherein patients with AML undergoing autologous stem cell transplantation are administered autologous cytotoxic T cells following the transplant with the goal of reducing the relapse rate. Dr. Ball is principal investigator on numerous clinical trials active at UCSD Medical Center ranging from Phase I investigator-initiated to Phase III trials. He has been a recipient of a NCI and NHLBI-sponsored UO1 grant from the NIH. He recently completed a study of a novel treatment of relapse following allogeneic stem cell transplantation. The infusion of a monoclonal antibody directed to the cytotoxic T lymphocyte antigen-4 (CTLA-4) was tested in series of patients with relapse for safety and efficacy. The study demonstrated the safety of this approach and some promising signs of efficacy. Dr. Ball has been the elected Secretary of the American Society of Blood and Marrow Transplantation and a member of the steering committee of the BMT Clinical Trials Network.

    Education and Training
    BS - Biochemistry, University of Maryland - 1968-1972
    MD - Case Western Reserve University - 1972-1976
    Resident - Hartford Hospital - 1976-1979
    Fellow - Hematology & Oncolog, University Hospitals of Cleveland - 1979-1981
    Fellow - Hematology & Oncology, Dartmouth- Hitchcock Medical Center - 1982-1983

    Collapse Research 
    Collapse Research Activities and Funding
    Adoptive T-Cell Therapy for Acute Leukemia
    NIH/NCI R21CA132277Jan 1, 2010 - Dec 31, 2012
    Role: Principal Investigator
    Symposium- Advances in Stem Cell Transplantation
    NIH/NCI R13CA102080May 2, 2003 - Apr 30, 2004
    Role: Principal Investigator
    CTLA-4 Blockade in Allo Stem Cell Transplantation
    NIH/NCI R01CA093891Sep 30, 2002 - Aug 31, 2008
    Role: Principal Investigator
    CTLA-4 Blockade to Stimulate Allogeneic Graft vs Tumor
    NIH/NHLBI U01HL069273Sep 30, 2001 - Sep 28, 2006
    Role: Principal Investigator
    TARGETED CELLULAR TOXICITY OF SCCL CELLS
    NIH/NCI R03CA072657Sep 30, 1997 - Jul 31, 1998
    Role: Principal Investigator
    MONOCLONAL ANTIBODIES/SMALL CELL CARCINOMA OF THE LUNG
    NIH/NCI R01CA037868Sep 30, 1985 - Sep 29, 1986
    Role: Principal Investigator
    Monoclonal Antibody for Treatment of Leukemia
    NIH/NCI R01CA031888Jun 1, 1983 - May 31, 1989
    Role: Principal Investigator
    MONOCLONAL ANTIBODIES REACTIVE WITH HUMAN LEUKEMIA CELLS
    NIH/NCI R23CA031888Jun 1, 1983 - May 31, 1986
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation. Blood. 2020 Jun 11; 135(24):2182-2191. Davids MS, Kim HT, Costello C, Herrera AF, Locke FL, Maegawa RO, Savell A, Mazzeo M, Anderson A, Boardman AP, Weber A, Avigan D, Chen YB, Nikiforow S, Ho VT, Cutler C, Alyea EP, Bachireddy P, Wu CJ, Ritz J, Streicher H, Ball ED, Bashey A, Soiffer RJ, Armand P. PMID: 32478814.
      View in: PubMed   Mentions:    Fields:    
    2. MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Med. 2020 05 19; 12(1):45. Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R. PMID: 32430031.
      View in: PubMed   Mentions:    Fields:    
    3. Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2020 Jul; 20(7):431-437.e2. Klebaner D, Koura D, Tzachanis D, Ball ED, Horwitz S, Goodman AM. PMID: 32284297.
      View in: PubMed   Mentions:    Fields:    
    4. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. Biol Blood Marrow Transplant. 2019 05; 25(5):955-964. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE. PMID: 30605731.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2019 04; 25(4):699-711. Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. PMID: 30423480.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica. 2019 04; 104(4):844-854. Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. PMID: 30381298.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    7. Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation. Hum Immunol. 2018 Dec; 79(12):848-854. Allen ES, Yang B, Garrett J, Ball ED, Maiers M, Morris GP. PMID: 30316972.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2018 05; 18(5):346-352.e5. Medeiros BC, Tanaka TN, Balaian L, Bashey A, Guzdar A, Li H, Messer K, Ball ED. PMID: 29572158.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    9. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. Br J Haematol. 2018 09; 182(6):916-920. Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. PMID: 28771676.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Nov; 23(11):1852-1860. Balakrishnan A, Gloude N, Sasik R, Ball ED, Morris GP. PMID: 28750779.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. What are the latest advancements in acute myeloid leukemia therapy? Future Oncol. 2017 Apr; 13(10):867-871. Goodman A, Ball ED. PMID: 28266249.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis. Oncology (Williston Park). 2017 02 15; 31(2):122-4, 126-8. Goodman AM, Rust M, Costello C, Ball ED. PMID: 28205192.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells. Biol Blood Marrow Transplant. 2017 Apr; 23(4):625-634. Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung YJ, Lee D, Kunkel L, Negrin RS, Bui JD. PMID: 28104514.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    14. CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. Cancer Cell. 2016 Nov 14; 30(5):792-805. Bajaj J, Konuma T, Lytle NK, Kwon HY, Ablack JN, Cantor JM, Rizzieri D, Chuah C, Oehler VG, Broome EH, Ball ED, van der Horst EH, Ginsberg MH, Reya T. PMID: 27908736.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    15. RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. Cell Stem Cell. 2016 11 03; 19(5):599-612. Crews LA, Balaian L, Delos Santos NP, Leu HS, Court AC, Lazzari E, Sadarangani A, Zipeto MA, La Clair JJ, Villa R, Kulidjian A, Storb R, Morris SR, Ball ED, Burkart MD, Jamieson CHM. PMID: 27570067.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    16. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016 Jul 14; 375(2):143-53. Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ. PMID: 27410923.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCellsCTClinical Trials
    17. Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia. Br J Haematol. 2016 Mar; 172(6):987-90. Wang HY, McMahon C, Ali SM, Young LE, Yekezare S, Ross JS, Ball ED. PMID: 26147192.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia. J Comput Biol. 2015 Apr; 22(4):266-88. Ong E, Szedlak A, Kang Y, Smith P, Smith N, McBride M, Finlay D, Vuori K, Mason J, Ball ED, Piermarocchi C, Paternostro G. PMID: 25844667.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    19. Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists. Cancer Immunol Immunother. 2015 Jun; 64(6):737-44. Zhong R, Li H, Messer K, Lane TA, Zhou J, Ball ED. PMID: 25795133.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    20. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants. Transfusion. 2014 Jul; 54(7):1857-63. Cunard R, Marquez II, Ball ED, Nelson CL, Corringham S, Clopton P, Sanchez AP, Lane T, Ward DM. PMID: 24372185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfall. Int J Clin Exp Pathol. 2014; 7(1):378-85. Johnson RL, Boisot S, Ball ED, Wang HY. PMID: 24427360.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. J Clin Oncol. 2013 Nov 20; 31(33):4199-206. Armand P, Nagler A, Weller EA, Devine SM, Avigan DE, Chen YB, Kaminski MS, Holland HK, Winter JN, Mason JR, Fay JW, Rizzieri DA, Hosing CM, Ball ED, Uberti JP, Lazarus HM, Mapara MY, Gregory SA, Timmerman JM, Andorsky D, Or R, Waller EK, Rotem-Yehudar R, Gordon LI. PMID: 24127452.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCTClinical Trials
    23. Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program. Bone Marrow Transplant. 2013 Jun; 48(6):777-81. Shaughnessy P, Uberti J, Devine S, Maziarz RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, Ball ED, Berryman R, Dugan M, Joyce R, Hsu FJ, Johns D, McSweeney P. PMID: 23178544.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    24. Phase II trial of parathyroid hormone after double umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1851-8. Ballen K, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P, Ball ED, Kamble R, Avigan D, Maziarz RT, Ho VT, Koreth J, Alyea E, Soiffer R, Wingard JR, Boussiotis V, Spitzer TR, Antin JH. PMID: 22766223.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    25. Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma. Pharmacotherapy. 2012 Jul; 32(7):596-603. Lor KW, Helmons PJ, Belew H, Lane JR, Ball ED. PMID: 22760691.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Increased Vacuolar ATPase Activity Correlated With CAM Induction in Mesembryanthemum crystallinum and Kalanchoë blossfeldiana cv. Tom Thumb. J Plant Physiol. 1985 Jan; 117(5):451-68. Struve I, Weber A, Lüttge U, Ball E, Smith JA. PMID: 23195866.
      View in: PubMed   Mentions: 4     Fields:    
    27. VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia. J Med Chem. 2012 Jan 26; 55(2):725-34. Heidary DK, Huang G, Boucher D, Ma J, Forster C, Grey R, Xu J, Arnost M, Choquette D, Chen G, Zhou JH, Yao YM, Ball ED, Namchuk M, Davies RJ, Henkel G. PMID: 22221201.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    28. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant. 2012 Feb; 18(2):280-8. Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ. PMID: 21810400.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    29. Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support. Int J Breast Cancer. 2011; 2011:523276. von Drygalski A, Tran TB, Messer K, Pu M, Corringham S, Nelson C, Ball ED. PMID: 22295228.
      View in: PubMed   Mentions:
    30. Idiotype immunization following high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant. 2012 Feb; 18(2):257-64. Holman PR, Costello C, deMagalhaes-Silverman M, Corringham S, Castro J, Ball ED. PMID: 21736867.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    31. Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer. 2012 Jan 15; 118(2):418-27. Cortes J, Kantarjian H, Ball ED, Dipersio J, Kolitz JE, Fernandez HF, Goodman M, Borthakur G, Baer MR, Wetzler M. PMID: 21717444.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    32. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support Care Cancer. 2011 Dec; 19(12):2015-20. Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, Shaikh F, Natarajan L. PMID: 21116652.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells. Biol Blood Marrow Transplant. 2011 May; 17(5):682-92. Zhou J, Bashey A, Zhong R, Corringham S, Messer K, Pu M, Ma W, Chut T, Soiffer R, Mitrovich RC, Lowy I, Ball ED. PMID: 20713164.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    34. Monoclonal antibodies in the treatment of hematologic malignancy. Best Pract Res Clin Haematol. 2010 Sep; 23(3):403-16. Ball ED, Broome HE. PMID: 21112039.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    35. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences. Biol Blood Marrow Transplant. 2011 Apr; 17(4):566-73. Espinosa-Aguilar L, Green JS, Forrest GN, Ball ED, Maziarz RT, Strasfeld L, Taplitz RA. PMID: 20708084.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    36. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). Biol Blood Marrow Transplant. 2011 Apr; 17(4):558-65. Bashey A, Owzar K, Johnson JL, Edwards PS, Kelly M, Baxter-Lowe LA, Devine S, Farag S, Hurd D, Ball E, McCarthy P, Lister J, Shea TC, Linker C. PMID: 20674758.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    37. Toxicity-evaluation designs for phase I/II cancer immunotherapy trials. Stat Med. 2010 Mar 30; 29(7-8):712-20. Messer K, Natarajan L, Ball ED, Lane TA. PMID: 20213706.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Increasing the punch of reduced-intensity transplants. Blood. 2009 Dec 24; 114(27):5410-1. Ball ED. PMID: 20035041.
      View in: PubMed   Mentions:    Fields:    
    39. Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD. J Oncol Pharm Pract. 2011 Jun; 17(2):85-90. Trivedi M, Martinez S, Corringham S, Medley K, Ball ED. PMID: 20015929.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia. Biol Blood Marrow Transplant. 2009 Oct; 15(10):1306-13. Jung AS, Holman PR, Castro JE, Carrier EK, Bashey A, Lane TA, Nelson CL, Pu M, Messer K, Corringham SM, Ball ED. PMID: 19747639.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transplant. 2009 Jun; 43(12):895-908. Trivedi M, Martinez S, Corringham S, Medley K, Ball ED. PMID: 19363527.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    42. CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood. 2009 Feb 12; 113(7):1581-8. Bashey A, Medina B, Corringham S, Pasek M, Carrier E, Vrooman L, Lowy I, Solomon SR, Morris LE, Holland HK, Mason JR, Alyea EP, Soiffer RJ, Ball ED. PMID: 18974373.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCTClinical Trials
    43. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells. Exp Hematol. 2008 Apr; 36(4):486-94. Zhong RK, Lane TA, Ball ED. PMID: 18249062.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    44. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation. Transfusion. 2007 Nov; 47(11):2153-60. Bashey A, Donohue M, Liu L, Medina B, Corringham S, Ihasz A, Carrier E, Castro JE, Holman PR, Xu R, Law P, Ball ED, Lane TA. PMID: 17958545.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    45. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant. 2008 Feb; 41(3):275-8. Liu J, Malhotra R, Voltarelli J, Stracieri AB, Oliveira L, Simoes BP, Ball ED, Carrier E. PMID: 17952128.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol. 2007 Jan; 136(2):237-48. Nearman ZP, Wlodarski M, Jankowska AM, Howe E, Narvaez Y, Ball E, Maciejewski JP. PMID: 17156396.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    47. Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk. Leukemia. 2006 Dec; 20(12):2093-101. Balaian L, Ball ED. PMID: 17051243.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    48. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs. Exp Hematol. 2006 Jun; 34(6):728-35. Nguyen DH, Ball ED, Varki A. PMID: 16728277.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    49. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2224-31. Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED. PMID: 16609038.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    50. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system. Cytotherapy. 2006; 8(1):3-12. Zhong RK, Loken M, Lane TA, Ball ED. PMID: 16627340.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    51. Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. Leuk Res. 2006 Apr; 30(4):503-6. Bashey A, Liu L, Ihasz A, Medina B, Corringham S, Keese K, Carrier E, Castro JE, Holman P, Lane TA, Hassidim K, Ball ED. PMID: 16303178.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Bone Marrow Transplant. 2005 Feb; 35(3):247-52. Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B. PMID: 15580282.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    53. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways. Exp Hematol. 2005 Feb; 33(2):199-211. Balaian L, Ball ED. PMID: 15676214.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    54. T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE). Bone Marrow Transplant. 2005 Jan; 35(2):205-6. Kamrava MR, Anderson EM, Kalunian K, Bashey A, Abshey A, Holman P, Medina B, Ball ED, Carrier E. PMID: 15543199.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    55. Targeting gastrin-releasing peptide receptors for cancer treatment. Anticancer Drugs. 2004 Nov; 15(10):921-7. Zhou J, Chen J, Mokotoff M, Ball ED. PMID: 15514561.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    56. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma. Bone Marrow Transplant. 2004 Oct; 34(7):581-7. Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E. PMID: 15273714.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Summary of the 12th international symposium on recent advances in stem cell transplantation. Exp Hematol. 2004 Oct; 32(10):881-4. Ball ED, Ho AD. PMID: 15504542.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    58. Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies. Leuk Res. 2004 Aug; 28(8):821-9. Balaian L, Ball ED. PMID: 15203280.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    59. Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells. Exp Hematol. 2004 May; 32(5):470-5. Zhong R, Law P, Wong D, Merzouk A, Salari H, Ball ED. PMID: 15145215.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    60. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells. Cytotherapy. 2004; 6(4):318-27. Lane TA, Bashey A, Carrier E, Holman P, Castro J, Mullen M, Ward DM, Ada O, Ball ED. PMID: 16146884.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    61. Update in hematology. Ann Intern Med. 2003 Dec 02; 139(11):916-22. Ball ED. PMID: 14644894.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    62. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4953-60. Zhou J, Chen J, Mokotoff M, Zhong R, Shultz LD, Ball ED. PMID: 14581370.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    63. FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia. Bone Marrow Transplant. 2003 Sep; 32(6):581-5. Tanner ML, Hoh CK, Bashey A, Holman P, Sun C, Broome HE, Lane T, Ball ED, Carrier E. PMID: 12953130.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression. Exp Hematol. 2003 May; 31(5):363-71. Balaian L, Zhong RK, Ball ED. PMID: 12763134.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    65. Development of allogeneic hematopoietic stem cell transplantation (HSCT). Cancer Treat Res. 2002; 110:1-37. Castro JE, Ball ED. PMID: 11908193.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    66. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia. Biol Blood Marrow Transplant. 2002; 8(10):557-68. Zhong RK, Rassenti LZ, Kipps TJ, Chen J, Law P, Yu JF, Ball ED. PMID: 12434951.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    67. Design and synthesis of non-peptidic inhibitors for the Syk C-terminal SH2 domain based on structure-based in-silico screening. J Med Chem. 2001 Dec 20; 44(26):4737-40. Niimi T, Orita M, Okazawa-Igarashi M, Sakashita H, Kikuchi K, Ball E, Ichikawa A, Yamagiwa Y, Sakamoto S, Tanaka A, Tsukamoto S, Fujita S, Tatsuta K, Maeda Y, Chikauchi K. PMID: 11741491.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    68. Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells. Leuk Res. 2001 Dec; 25(12):1115-25. Balaian L, Ball ED. PMID: 11684286.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    69. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion. Bone Marrow Transplant. 2001 Jul; 28(1):97-9. Voltarelli JC, Ahmed H, Paton EJ, Stracieri AB, Holman P, Bashey A, Coutinho M, Simoes BP, Ball ED, Carrier E. PMID: 11498752.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH(2)NH]-Phe(14))BN(6-14) and D-Trp-Gln-Trp-NH(2). J Pept Res. 2001 May; 57(5):383-9. Mokotoff M, Mocarski YM, Gentsch BL, Miller MR, Zhou JH, Chen J, Ball ED. PMID: 11350598.
      View in: PubMed   Mentions:    Fields:    
    71. Characterization of a new monoclonal antibody 6G7 that recognizes a unique antigen on myeloid and lymphoid cells. J Hematother Stem Cell Res. 2001 Apr; 10(2):237-46. Chen J, Zhou JH, Ball ED. PMID: 11359671.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    72. Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice. J Hematother Stem Cell Res. 2001 Feb; 10(1):95-105. Zhong RK, van de Winkel JG, Thepen T, Schultz LD, Ball ED. PMID: 11276363.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    73. Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support. Clin Oncol (R Coll Radiol). 2001; 13(6):434-7. Bashey A, Sundaram S, Corringham S, Jones V, Lancaster D, Silva-Gietzen J, Law P, Ball ED. PMID: 11824880.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up. Bone Marrow Transplant. 2000 Apr; 25(8):823-9. Ball ED, Wilson J, Phelps V, Neudorf S. PMID: 10808202.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    75. Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer. J Immunother. 2000 Jan; 23(1):154-60. deMagalhaes-Silverman M, Donnenberg A, Lembersky B, Elder E, Lister J, Rybka W, Whiteside T, Ball E. PMID: 10687148.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    76. Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation. Cytotherapy. 2000; 2(3):195-200. Bashey A, Corringham S, Gilpin E, Fields KK, Smilee RC, DeFrancisco C, Santos-Ada O, Holman P, Carrier E, Ho AD, Lane TA, Ball ED, Janssen WE, Law P. PMID: 12042042.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    77. Ex vivo purging and cell expansion. J Hematother Stem Cell Res. 1999 Oct; 8(5):457-8. Ball ED. PMID: 10791896.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    78. Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen. J Immunol. 1999 Aug 01; 163(3):1354-62. Zhong RK, Donnenberg AD, Zhang HF, Watkins S, Zhou JH, Ball ED. PMID: 10415035.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    79. Factors influencing mobilization and engraftment in patients with metastatic breast cancer undergoing PBSC transplantation. J Hematother. 1999 Apr; 8(2):167-72. de Magalhaes-Silverman M, Donnenberg AD, Lister J, Rybka W, Wilson J, Ball E. PMID: 10349910.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells. Eur J Haematol. 1998 Jul; 61(1):1-6. Takiyama N, Mohney T, Swaney W, Bahnson AB, Rice E, Beeler M, Scheirer-Fochler S, Ball ED, Barranger JA. PMID: 9688285.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    81. Regulation of p21(WAF1) expression during normal myeloid differentiation. Blood. 1998 Jun 15; 91(12):4531-42. Steinman RA, Huang J, Yaroslavskiy B, Goff JP, Ball ED, Nguyen A. PMID: 9616149.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    82. Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia. 1998 Jun; 12(6):899-906. White SM, Ball ED, Ehmann WC, Rao AS, Tweardy DJ. PMID: 9639418.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    83. Pneumoperitoneum without peritonitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998 Jun; 21(11):1153-4. de Magalhaes-Silverman M, Simpson J, Ball E. PMID: 9645580.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy. Bone Marrow Transplant. 1998 Jun; 21(12):1207-11. deMagalhaes-Silverman M, Hammert L, Lembersky B, Lister J, Rybka W, Ball E. PMID: 9674853.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood. 1997 Dec 01; 90(11):4313-20. Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones RB, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R. PMID: 9373242.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    86. Purging marrow or peripheral blood stem cells for autografting. Curr Opin Hematol. 1997 Nov; 4(6):423-8. Hammert LC, Ball ED. PMID: 9359000.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    87. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry. 1997 Oct 15; 30(5):249-63. Davis BH, Foucar K, Szczarkowski W, Ball E, Witzig T, Foon KA, Wells D, Kotylo P, Johnson R, Hanson C, Bessman D. PMID: 9383099.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 1997 Oct 01; 90(7):2730-7. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. PMID: 9326240.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    89. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow. J Hematother. 1997 Aug; 6(4):351-9. Neudorf SM, Rybka W, Ball E, Blatt J, Bloom E, Corey S, deMagalhaes-Silverman M, Koehler M, Lister J, Mierski J, Mirro J, Pincus S, Wilson J, Wollman M, Donnenberg AD. PMID: 9377073.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    90. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia. Bone Marrow Transplant. 1997 Jul; 20(2):175-7. deMagalhaes-Silverman M, Donnenberg A, Hammert L, Lister J, Myers D, Simpson J, Ball E. PMID: 9244424.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Purging autologous bone marrow with monoclonal antibodies for transplantation in acute myelogenous leukemia. Blood Rev. 1997 Jun; 11(2):80-90. Hammert LC, Ball ED. PMID: 9242991.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transplant. 1997 May; 19(9):943-5. Lister J, Simpson JK, deMagalhaes-Silverman MM, Rybka WB, Donnenberg AD, Myers DJ, Ball ED. PMID: 9156271.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. Thy-1 expression on blast cells from adult patients with acute myeloid leukemia. Leuk Res. 1997 May; 21(5):381-5. Kozii R, Wilson J, Persichetti J, Phelps V, Ball SE, Ball ED. PMID: 9225063.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    94. Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplant. 1997 Apr; 19(8):777-81. de Magalhaes-Silverman M, Lister J, Rybka W, Wilson J, Ball E. PMID: 9134168.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    95. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1997 Feb; 19(4):303-10. Kiss JE, Rybka WB, Winkelstein A, deMagalhaes-Silverman M, Lister J, D'Andrea P, Ball ED. PMID: 9051238.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    96. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer. Clin Cancer Res. 1997 Feb; 3(2):193-7. deMagalhaes-Silverman M, Bloom E, Lembersky B, Lister J, Pincus S, Rybka W, Voloshin M, Wilson J, Ball E. PMID: 9815672.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    97. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood. 1996 Oct 01; 88(7):2442-9. Chakraborty A, White SM, Schaefer TS, Ball ED, Dyer KF, Tweardy DJ. PMID: 8839834.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    98. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood. 1996 Sep 15; 88(6):2183-91. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD. PMID: 8822938.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    99. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 1996 Aug 15; 56(16):3763-70. Henderson RA, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ. PMID: 8706022.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    100. Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu model. Leuk Res. 1996 Jul; 20(7):581-9. Zhong RK, Donnenberg AD, Shultz LD, Swerdlow SH, Lee E, Rubin J, Kozii R, Chen J, Griffin DL, Wilson J, Ball ED. PMID: 8795692.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    101. Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets. Br J Haematol. 1996 May; 93(2):375-85. Silla LM, Pincus SM, Locker JD, Glover J, Elder EM, Donnenberg AD, Nardi NB, Bryant J, Ball ED, Whiteside TL. PMID: 8639431.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    102. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. Am J Clin Oncol. 1996 Apr; 19(2):169-73. deMagalhaes-Silverman M, Rybka WB, Lembersky B, Bloom EJ, Lister J, Pincus SM, Voloshin M, Wilson J, Ball ED. PMID: 8610643.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies. Bone Marrow Transplant. 1996 Mar; 17(3):329-33. deMagalhaes-Silverman M, Bloom EJ, Donnenberg A, Lister J, Pincus S, Rybka WB, Ball ED. PMID: 8704682.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    104. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. J Hematother. 1996 Feb; 5(1):39-48. Nimgaonkar M, Kemp A, Lancia J, Ball ED. PMID: 8646480.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    105. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy. Exp Hematol. 1995 Dec; 23(14):1633-41. Nimgaonkar M, Mierski J, Beeler M, Kemp A, Lancia J, Mannion-Henderson J, Mohney T, Bahnson A, Rice E, Ball ED. PMID: 8542958.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    106. Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors. Exp Hematol. 1995 Dec; 23(14):1628-32. Mannion-Henderson J, Kemp A, Mohney T, Nimgaonkar M, Lancia J, Beeler MT, Mierski J, Bahnson AB, Ball ED, Barranger JA. PMID: 8542957.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    107. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64). Clin Cancer Res. 1995 Nov; 1(11):1319-25. Chen J, Zhou JH, Ball ED. PMID: 9815927.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    108. Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995. J Hematother. 1995 Oct; 4(5):345-9. Fanger MW, Ball ED, Drakeman DL. PMID: 8581367.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    109. Lysis of small cell carcinoma of the lung (SCCL) cells by cytokine-activated monocytes and natural killer cells in the presence of bispecific immunoconjugates containing a gastrin-releasing peptide (GRP) analog or a GRP antagonist. J Hematother. 1995 Oct; 4(5):369-76. Chen J, Zhou JH, Mokotoff M, Fanger MW, Ball ED. PMID: 8581371.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    110. Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor. Br J Haematol. 1995 Oct; 91(2):269-74. Zhong RK, Kozii R, Ball ED. PMID: 8547061.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    111. Phase I clinical trial of serotherapy in patients with acute myeloid leukemia with an immunoglobulin M monoclonal antibody to CD15. Clin Cancer Res. 1995 Sep; 1(9):965-72. Ball ED, Selvaggi K, Hurd D, Herzig R, Clark L, Malley V, Persichetti J, deMagelhaus-Silverman M. PMID: 9816068.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    112. The role of natural killer cells in the treatment of chronic myeloid leukemia. J Hematother. 1995 Aug; 4(4):269-79. Silla LM, Whiteside TL, Ball ED. PMID: 7489141.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    113. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period. Clin Cancer Res. 1995 Jun; 1(6):607-14. Lister J, Rybka WB, Donnenberg AD, deMagalhaes-Silverman M, Pincus SM, Bloom EJ, Elder EM, Ball ED, Whiteside TL. PMID: 9816022.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    114. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am J Hematol. 1995 May; 49(1):29-38. Davey FR, Abraham N, Brunetto VL, MacCallum JM, Nelson DA, Ball ED, Griffin JD, Baer MR, Wurster-Hill D, Mayer RJ. PMID: 7741135.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    115. Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells. Br J Haematol. 1995 Apr; 89(4):712-8. Silla LM, Chen J, Zhong RK, Whiteside TL, Ball ED. PMID: 7772507.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    116. Introduction: workshop summary of the CD15 monoclonal antibody panel from the Fifth International Workshop on Leukocyte Antigens. Eur J Morphol. 1995 Apr; 33(2):95-100. Ball ED. PMID: 7488522.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    117. Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation. 1995 Mar 27; 59(6):871-4. Rybka WB, Fontes PA, Rao AS, Winkelstein A, Ricordi C, Ball ED, Starzl TE. PMID: 7701582.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    118. A unique population of CD34+ cells in cord blood. Stem Cells. 1995 Mar; 13(2):158-66. Nimgaonkar MT, Roscoe RA, Persichetti J, Rybka WB, Winkelstein A, Ball ED. PMID: 7540469.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    119. Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1995 Feb; 15(2):283-6. Memon M, deMagalhaes-Silverman M, Bloom EJ, Lister J, Myers DJ, Pincus SM, Rybka WB, Ball ED. PMID: 7773219.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS. Transplant Proc. 1994 Jun; 26(3):1302-3. Ricordi C, Tzakis AG, Rybka WB, Fontes P, Ball ED, Trucco M, Kocova M, Triulzi D, McMichael J, Doyle H. PMID: 7913262.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    121. Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene. Gene Ther. 1994 May; 1(3):176-84. Bahnson AB, Nimgaonkar M, Fei Y, Boggs SS, Robbins PD, Ohashi T, Dunigan J, Li J, Ball ED, Barranger JA. PMID: 7584079.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    122. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA. Gene Ther. 1994 May; 1(3):201-7. Nimgaonkar MT, Bahnson AB, Boggs SS, Ball ED, Barranger JA. PMID: 7584082.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    123. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood. 1994 Apr 15; 83(8):2345-51. Zhong RK, Donnenberg AD, Rubin J, Ball ED. PMID: 7512845.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    124. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 1994 Mar 15; 83(6):1603-11. Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD. PMID: 8123851.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    125. Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant. 1994 Mar-Apr; 3(2):187-92. Ricordi C, Tzakis AG, Zeevi A, Rybka WB, Demetris AJ, Fontes PA, Nalesnik MA, Trucco M, Ukah FO, Ball ED. PMID: 8012734.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    126. A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells. J Hematother. 1994; 3(2):121-7. Rubin J, Malley V, Ball ED. PMID: 7922015.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    127. Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci. 1993 Apr; 3(1):76-77. Ricordi C, Tzakis AG, Demetris AJ, Zeevi A, Rybka WB, Nalesnik MA, Ukah FO, Fontes PA, Ball ED, Starzl TE. PMID: 21572946.
      View in: PubMed   Mentions: 2     Fields:    
    128. Autologous bone marrow transplantation for adult acute leukemia. Hematol Oncol Clin North Am. 1993 Feb; 7(1):201-31. Ball ED, Rybka WB. PMID: 8449859.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    129. ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst. 1992 Nov 04; 84(21):1626-32. Taylor JA, Sandler DP, Bloomfield CD, Shore DL, Ball ED, Neubauer A, McIntyre OR, Liu E. PMID: 1433344.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    130. Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myeloid leukemia. Bone Marrow Transplant. 1992 Sep; 10(3):261-6. Howell AL, Stukel TA, Bloomfield CD, Ball ED. PMID: 1422480.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    131. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow. Bone Marrow Transplant. 1992 Feb; 9(2):129-37. Ericson SG, Colby E, Welch L, Ball ED. PMID: 1373982.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    132. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow. Prog Clin Biol Res. 1992; 377:97-110; discussion 111. Ball ED, Mills L, Hurd D, McMillan R, Gingrich R. PMID: 1438450.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    133. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). J Hematother. 1992; 1(1):85-94. Ball ED, Guyre PM, Mills L, Fisher J, Dinces NB, Fanger MW. PMID: 1365020.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    134. Immune markers in hematologic malignancies. Crit Rev Oncol Hematol. 1991 Dec; 11(4):267-97. Vaickus L, Ball ED, Foon KA. PMID: 1777090.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    135. Expression of the CD15 antigen on normal and leukemic myeloid cells: effects of neuraminidase and variable detection with a panel of monoclonal antibodies. Mol Immunol. 1991 Sep; 28(9):951-8. Ball ED, Schwarz LM, Bloomfield CD. PMID: 1681429.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    136. Isodicentric chromosome 18q as sole abnormality in a histologically normal bone marrow from a patient with diffuse large-cell non-Hodgkin's lymphoma. Cancer Genet Cytogenet. 1991 Jul 15; 54(2):233-7. Wurster-Hill DH, Vredenburgh JJ, Davis BH, Mills LE, Ball ED. PMID: 1884356.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    137. Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device. Bone Marrow Transplant. 1991 Jul; 8(1):35-40. Ball ED, Powers FJ, Vredenburgh JJ, Heath CA, Converse AO. PMID: 1655139.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood. 1991 May 15; 77(10):2242-50. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL. PMID: 1709379.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    139. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Cancer Res. 1991 May 01; 51(9):2451-5. Vredenburgh JJ, Simpson W, Memoli VA, Ball ED. PMID: 1673088.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    140. Allorecognition of HLA DR2 and DR5 molecules by V-beta-8-positive T-cell clones. Scand J Immunol. 1991 Feb; 33(2):131-9. Wilson KE, Ball E, Stasny P, Capra JD. PMID: 2017654.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    141. Immunophenotyping of acute myeloid leukemia cells. Clin Lab Med. 1990 Dec; 10(4):721-36. Ball ED. PMID: 2272171.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    142. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads. Cancer Res. 1990 Nov 15; 50(22):7216-20. Vredenburgh JJ, Ball ED. PMID: 2171759.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    143. Trisomy 13: a new recurring chromosome abnormality in acute leukemia. Blood. 1990 Oct 15; 76(8):1614-21. Döhner H, Arthur DC, Ball ED, Sobol RE, Davey FR, Lawrence D, Gordon L, Patil SR, Surana RB, Testa JR. PMID: 1698482.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    144. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies. Bone Marrow Transplant. 1990 Oct; 6(4):277-80. Ball ED, Vredenburgh JJ, Mills LE, Cornwell GG, Schwarz L, Howell AL, Troy K. PMID: 1982228.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Molecular genetics of Drosophila alpha-actinin: mutant alleles disrupt Z disc integrity and muscle insertions. J Cell Biol. 1990 Jun; 110(6):1999-2011. Fyrberg E, Kelly M, Ball E, Fyrberg C, Reedy MC. PMID: 2112549.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    146. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow. Blood. 1990 Mar 01; 75(5):1199-206. Ball ED, Mills LE, Cornwell GG, Davis BH, Coughlin CT, Howell AL, Stukel TA, Dain BJ, McMillan R, Spruce W. PMID: 2306522.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    147. Induction of differentiation in blast cells and leukemia colony-forming cells from patients with acute myeloid leukemia. Blood. 1990 Feb 01; 75(3):721-9. Howell AL, Stukel TA, Bloomfield CD, Davey FR, Ball ED. PMID: 2105108.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    148. Autologous bone marrow transplantation in the treatment of acute myeloid leukemia: the Dartmouth experience and a review of literature. Cancer Invest. 1990; 8(2):181-90. Mills LE, Cornwell GG, Ball ED. PMID: 2205335.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    149. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement. Prog Clin Biol Res. 1990; 333:165-70. Mills LE, Ball ED, Howell AL, Cornwell GG, Thompson L, Spruce W, Miller WE, McMillan R. PMID: 2308980.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    150. Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction. Prog Clin Biol Res. 1990; 333:499-506. Ball ED, Mills LE, Neubauer A, Liu E. PMID: 2408063.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    151. Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation. Am J Hematol. 1989 Oct; 32(2):81-7. Davis BH, Bigelow N, Ball ED, Mills L, Cornwell GG. PMID: 2474249.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    152. Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine. Eur J Immunol. 1989 Sep; 19(9):1741-6. Kimura H, Buescher ES, Ball ED, Marcus DM. PMID: 2571506.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    153. Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells. Blood. 1989 May 15; 73(7):1951-6. Ball ED, McDermott J, Griffin JD, Davey FR, Davis R, Bloomfield CD. PMID: 2469504.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    154. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture. Bone Marrow Transplant. 1989 May; 4(3):309-15. Ball ED, Keefe KA, McDermott JM. PMID: 2659116.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    155. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells. Bone Marrow Transplant. 1989 May; 4(3):317-22. Howell AL, Fogg-Leach M, Davis BH, Ball ED. PMID: 2659117.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    156. A novel monoclonal antibody, SCCL 175, with specificity for small cell neuroendocrine carcinoma of the lung. Cancer Res. 1988 Dec 15; 48(24 Pt 1):7319-22. Memoli VA, Jordan AG, Ball ED. PMID: 2847869.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    157. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies. Bone Marrow Transplant. 1988 Sep; 3(5):387-92. Ball ED. PMID: 3056546.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    158. Immunotoxins for ex vivo marrow purging in autologous bone marrow transplantation for acute nonlymphocytic leukemia. Transplantation. 1988 Aug; 46(2):240-5. Myers DE, Uckun FM, Ball ED, Vallera DA. PMID: 2457265.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    159. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation. J Cell Biochem. 1988 Apr; 36(4):445-52. Ball ED, Howell AL. PMID: 3288649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    160. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells. Exp Hematol. 1988 Mar; 16(3):176-83. Howell AL, Miller R, Keefe KA, McIntyre OR, Stockner M, Sullivan R, Hibbert SR, Noelle RJ, Ball ED. PMID: 3422192.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    161. Sequences of the VH and VL regions of murine monoclonal antibodies against 3-fucosyllactosamine. J Immunol. 1988 Feb 15; 140(4):1212-7. Kimura H, Cook R, Meek K, Umeda M, Ball E, Capra JD, Marcus DM. PMID: 2893825.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    162. Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia. Med Pediatr Oncol. 1988; 16(3):187-9. Vredenburgh JJ, McIntyre OR, Cornwell GG, Ball ED, Cornell CJ, Mills LE, O'Donnell JF. PMID: 3380061.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    163. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells. Cancer Res. 1987 Dec 15; 47(24 Pt 1):6556-9. Ball ED, Keefe KA, Colby E. PMID: 2824035.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    164. Magnetic affinity colloid (MAC) cell separation of leukemia cells from autologous bone marrow aspirates. Leuk Res. 1987; 11(12):1067-77. Reading CL, Thomas MW, Hickey CM, Chandran M, Tindle S, Ball ED, Poynton CH, Dicke KA. PMID: 3695563.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    165. Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line. Exp Hematol. 1986 Dec; 14(11):998-1005. Ball ED, Howell AL, Shen L. PMID: 3096754.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    166. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies. Blood. 1986 Dec; 68(6):1311-5. Ball ED, Mills LE, Coughlin CT, Beck JR, Cornwell GG. PMID: 3535927.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    167. Sialylated glycolipid antigens on human leukemic cell lines. Exp Hematol. 1986 Aug; 14(7):643-7. Spitalnik SL, Spitalnik PF, Civin CI, Ball ED, Schwartz JF, Ginsburg V. PMID: 3732420.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    168. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon. Cancer Res. 1986 May; 46(5):2335-9. Ball ED, Sorenson GD, Pettengill OS. PMID: 3008987.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    169. Idiotypic determinants of monoclonal antibodies that bind to 3-fucosyllactosamine. J Immunol. 1986 Apr 01; 136(7):2562-7. Umeda M, Diego I, Ball ED, Marcus DM. PMID: 2419441.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    170. Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon. Cancer Immunol Immunother. 1986; 22(3):211-6. Ball ED, Nichols KE, Pettengill OS, Sorenson GD, Fanger MW. PMID: 3015408.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    171. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. J Immunol. 1985 Sep; 135(3):1929-36. Maliszewski CR, Ball ED, Graziano RF, Fanger MW. PMID: 3894519.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    172. Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis. Blood. 1985 Sep; 66(3):649-54. Howell AL, Ball ED. PMID: 3861203.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    173. 1,25-Dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Mol Immunol. 1985 May; 22(5):567-72. Rigby WF, Shen L, Ball ED, Fanger MW. PMID: 3860730.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    174. The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells. Blood. 1985 Apr; 65(4):858-61. Rigby WF, Ball ED, Guyre PM, Fanger MW. PMID: 2579688.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    175. Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest. 1985 Feb; 75(2):746-53. Sabbath KD, Ball ED, Larcom P, Davis RB, Griffin JD. PMID: 3855866.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    176. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood. 1984 Nov; 64(5):1110-5. Rigby WF, Shen L, Ball ED, Guyre PM, Fanger MW. PMID: 6548394.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    177. Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). J Immunol. 1984 May; 132(5):2424-8. Ball ED, Guyre PM, Glynn JM, Rigby WF, Fanger MW. PMID: 6425403.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    178. Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest. 1984 Apr; 73(4):1072-7. Ball ED, Guyre PM, Shen L, Glynn JM, Maliszewski CR, Baker PE, Fanger MW. PMID: 6231309.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    179. Monoclonal antibodies reactive with small cell carcinoma of the lung. J Natl Cancer Inst. 1984 Mar; 72(3):593-8. Ball ED, Graziano RF, Pettengill OS, Sorenson GD, Fanger MW. PMID: 6321841.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    180. Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. Blood. 1983 Dec; 62(6):1203-10. Ball ED, Bernier GM, Cornwell GG, McIntyre OR, O'Donnell JF, Fanger MW. PMID: 6605773.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    181. The expression and modulation of human myeloid-specific antigens during differentiation of the HL-60 cell line. Blood. 1983 Jun; 61(6):1215-21. Graziano RF, Ball ED, Fanger MW. PMID: 6188506.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    182. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody. J Immunol. 1983 Jun; 130(6):2937-41. Ball ED, Graziano RF, Fanger MW. PMID: 6574189.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    183. The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation. Blood. 1983 Mar; 61(3):456-63. Ball ED, Fanger MW. PMID: 6186318.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    184. The use of myeloid-specific monoclonal antibodies in the diagnosis of leukemia. Diagn Immunol. 1983; 1(2):90-5. Ball ED, Fanger MW. PMID: 6209052.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    185. Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. Proc Natl Acad Sci U S A. 1982 Sep; 79(17):5374-8. Ball ED, Graziano RF, Shen L, Fanger MW. PMID: 6752945.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    186. Monoclonal antibodies reactive with human myeloid leukaemia cells. Clin Exp Immunol. 1982 Jun; 48(3):655-65. Ball ED, Fanger MW. PMID: 6956470.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    187. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells. J Immunol. 1982 Mar; 128(3):1476-81. Ball ED, Kadushin JM, Schacter B, Fanger MW. PMID: 6948897.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    188. Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med. 1980 Feb; 92(2 Pt 1):149-55. Myers TJ, Wakem CJ, Ball ED, Tremont SJ. PMID: 7188723.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans